Phase 3 Trial of Modified Vaccinia Ankara as a Smallpox Vaccine
In today's New England Journal of Medicine, researchers describe the phase 3 trial results of the newly approved modified vaccinia Ankara ...
Tag: Smallpox
USAMRIID Study Leads to Approval of New Smallpox Vaccine
A new vaccine approved in the U.S. on Sept. 24 prevents both smallpox and the related disease monkeypox in adults. ...
Why Do We Need a New Smallpox Vaccine?
The FDA approved the Jynneos Smallpox and Monkeypox Vaccine last week. The live, non-replicating vaccine is made from a vaccinia ...
BioFactura’s Smallpox Biodefense Therapeutic Awarded $67M BARDA Contract
BioFactura, Inc. today announced a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA) valued at up to ...
FDA Approves Jynneos to Prevent Smallpox and Monkeypox
The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the ...
Explosion Confirmed at Russian Lab Storing Smallpox, Ebola
One worker was hospitalized after a gas explosion on Sep. 16 caused a fire to break out at the Russian ...
US Invests Additional 44 Million in Smallpox Vaccine Manufacturing
Bavarian Nordic A/S announced on Jan. 18 that the U.S. Biomedical Advanced Research and Development Authority (BARDA) has exercised another ...
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox
SIGA Technologies, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United ...
CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to Emergent ...
Factoring Immunosuppression into Smallpox Outbreak Planning
Unprecedented levels of immunosuppression in countries like Australia and the US must be considered in planning for the risk of ...
USAMRIID-Bavarian Nordic Smallpox Vaccine Phase 3 Study
Concept drawing of vaccinia. Credit: Shutterstock Bavarian Nordic announced on Feb. 6 the results of a ...
U.S. Seeks to Develop Late-Stage Smallpox Antivirals
The etiological agent responsible for smallpox disease, Variola viridae (VARV) is responsible for the deaths of hundreds of millions of ...
BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures ...
Bavarian Nordic Highlights Smallpox Orders, Vaccine Development
Bavarian Nordic A/S this week updated investors on its progress for the first three quarters of 2017, highlighting MVA-BN IMVAMUNE® ...
Emergent BioSolutions to Acquire Smallpox Vaccine Business from Sanofi
The only FDA-licensed smallpox vaccine, ACAM2000 (Smallpox (Vaccinia) Vaccine, Live), will be acquired from Sanofi by Emergent BioSolutions under a ...
Smallpox Vaccine Potency Testing
The Centers for Disease Control and Prevention has announced intentions to award a sole source contract to Sanofi Pasteur Biologics, ...
Immunization Research Supports Military Force Readiness
Vaccinations have played a prominent role in U.S. military history. George Washington ordered smallpox vaccine for his soldiers during the ...
CDC Program Helps Democratic Republic of the Congo Combat Monkeypox
The Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases Extramural Research Program Office has ...
Smallpox Research Blurs Line Between Ancient Diseases, Emerging Infections
New research suggests that smallpox, a pathogen that caused millions of deaths worldwide, may not be an ancient disease but ...
Intravenous Brincidofovir May Improve Countermeasure’s Tolerability
Broad-spectrum antiviral Brincidofovir has shown favorable tolerability in its intravenous formulation, according to preclinical data presented by Chimerix at the ...
ADVERTISEMENT.
